Loading Valuation Snapshot...
Stock DNA
Pharmaceuticals & Biotechnology
INR 395 Cr (Micro Cap)
263.00
40
0.00%
0.00
0.27%
0.75
Revenue and Profits:
Net Sales:
78 Cr
(Quarterly Results - Sep 2026)
Net Profit:
5 Cr
Total Returns (Price + Dividend) 
Company does not have enough history
Risk Adjusted Returns v/s 
Returns Beta
Beta has not been calculated since enough price history is not available
News
No Recent News for the Company
Announcements 
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
12-Nov-2026 | Source : BSEPlease find attached.
Announcement under Regulation 30 (LODR)-Change in Management
12-Nov-2026 | Source : BSEPlease find attached.
Board Meeting Outcome for Outcome Of Board Meeting
12-Nov-2026 | Source : BSEPlease find attached.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
1.14
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
22.93%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
7.05%
ROCE (avg)
0
ROE (avg)
9.04%
Valuation key factors
Factor
Value
P/E Ratio
263
Industry P/E
40
Price to Book Value
0.71
EV to EBIT
25.53
EV to EBITDA
12.86
EV to Capital Employed
0.71
EV to Sales
1.52
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
2.76%
ROE (Latest)
0.27%
Technicals key factors
Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
KST
Dow Theory
OBV
Shareholding Snapshot : Nov 2026
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 6 Schemes (0.21%)
FIIs
Held by 67 FIIs (2.44%)
Promoter with highest holding
Bhaskara Rao Bollineni (67.04%)
Highest Public shareholder
Soptex Developements Limited (1.45%)
Individual Investors Holdings
24.69%
Quarterly Results Snapshot (Standalone) - Sep'26 - QoQ
Sep'26
Jun'26
Change(%)
Net Sales
78.46
90.39
-13.20%
Operating Profit (PBDIT) excl Other Income
10.34
9.98
3.61%
Interest
0.03
0.04
-25.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
4.89
4.66
4.94%
Operating Profit Margin (Excl OI)
13.18%
11.04%
2.14%
Values in Rs Cr.
Net Sales
QoQ Growth in quarter ended Sep 2026 is -13.20% vs 66.96% in Jun 2026
Standalone Net Profit
QoQ Growth in quarter ended Sep 2026 is 4.94% vs 464.06% in Jun 2026
Annual Results Snapshot (Standalone) - Mar'26
Mar'26
Change(%)
Net Sales
246.15
NA
NA
Operating Profit (PBDIT) excl Other Income
29.17
NA
NA
Interest
12.86
NA
NA
Exceptional Items
-0.28
NA
NA
Standalone Net Profit
1.21
NA
NA
Operating Profit Margin (Excl OI)
11.85%
NA%
NA
Values in Rs Cr.
Net Sales
Not Applicable: The company has declared_date for only one period
Standalone Net Profit
Not Applicable: The company has declared_date for only one period